Deutsche Bank AG restated their hold rating on shares of GlaxoSmithKline plc (LON:GSK) in a research report sent to investors on Wednesday morning. The firm currently has a GBX 1,870 ($23.14) target price on the stock.

Other analysts have also recently issued research reports about the stock. Societe Generale cut shares of GlaxoSmithKline plc to a sell rating and lifted their price target for the company from GBX 1,300 ($16.09) to GBX 1,320 ($16.34) in a report on Thursday, September 8th. JPMorgan Chase & Co. reiterated a neutral rating and issued a GBX 1,900 ($23.51) price target on shares of GlaxoSmithKline plc in a report on Tuesday, August 23rd. BNP Paribas reiterated an underperform rating and issued a GBX 1,520 ($18.81) price target on shares of GlaxoSmithKline plc in a report on Friday, September 30th. Liberum Capital reiterated a buy rating and issued a GBX 1,900 ($23.51) price target on shares of GlaxoSmithKline plc in a report on Tuesday, September 20th. Finally, Citigroup Inc. reiterated a buy rating and issued a GBX 1,800 ($22.28) price target on shares of GlaxoSmithKline plc in a report on Wednesday, October 5th. Three equities research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and eight have assigned a buy rating to the company’s stock. GlaxoSmithKline plc currently has an average rating of Hold and an average target price of GBX 1,687.13 ($20.88).

Shares of GlaxoSmithKline plc (LON:GSK) opened at 1688.45 on Wednesday. The stock has a 50 day moving average of GBX 1,648.78 and a 200 day moving average of GBX 1,560.13. GlaxoSmithKline plc has a 1-year low of GBX 1,277.25 and a 1-year high of GBX 1,745.56. The company’s market cap is GBX 82.08 billion.

The company also recently disclosed a dividend, which will be paid on Thursday, October 13th. Stockholders of record on Thursday, August 11th will be paid a GBX 19 ($0.24) dividend. This represents a dividend yield of 1.12%. The ex-dividend date of this dividend is Thursday, August 11th.

In other news, insider Witty,Sir Andrew P sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, July 27th. The stock was sold at an average price of GBX 1,693 ($20.95), for a total value of £169,300 ($209,529.70). Also, insider Slaoui,Moncef acquired 28 shares of GlaxoSmithKline plc stock in a transaction dated Friday, August 12th. The stock was purchased at an average price of GBX 2,208 ($27.33) per share, with a total value of £618.24 ($765.15).

GlaxoSmithKline plc Company Profile

GlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company’s segments include Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare.

Receive News & Stock Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related stocks with our FREE daily email newsletter.